Abdulatif AL-Haj | Cytoskeleton Cell Motility | Innovative Research Award

Published on by Cell Biologist

Dr. Abdulatif AL-Haj | Cytoskeleton Cell Motility | Innovative Research Award

Dr. Abdulatif AL-Haj | Ruhr Universität Bochum | Germany

Dr. Abdulatif Al Haj is a highly accomplished biochemist and molecular cardiology researcher originally from Syria, currently residing in Germany. With extensive academic and professional experience across Europe and the Middle East, Dr. Al Haj has built a multidisciplinary career in molecular biology, biotechnology, and medical education. He holds a doctorate in biology and biotechnology, with a strong focus on actin dynamics and cardiovascular disease. Fluent in Arabic, German, English, and French, he has effectively bridged scientific research with public health, education, and social integration roles. His work includes teaching, paramedic service during the pandemic, and involvement in migrant integration and healthcare initiatives. He has contributed to peer-reviewed publications and collaborated with notable researchers in Germany. Dr. Al Haj exemplifies international scientific cooperation and interdisciplinary application of biosciences for societal benefit.

publication profile:

scopus

🔍 Strengths for the Award:

  • 🔬 Cutting-Edge Research: Key discoveries in actin cytoskeleton regulation and thymosin beta4′s role in cardiac repair

  • 🌍 Global Impact: Extensive collaborations in Germany and Syria, advancing both education and research

  • 📚 Scientific Output: Author of multiple high-impact journal articles and presenter in international scientific symposia

  • 👨‍🏫 Cross-disciplinary Excellence: Combines life sciences, education, and healthcare

  • 🧪 Innovative Thinking: Integrated research on cofilin/ADF, Arp2/3 complex, and cardiomyocyte remodeling

🚧 Areas for Improvement:

  • Broader dissemination of findings through more international conferences

  • Increase involvement in grant-funded principal investigator (PI) roles

  • Enhance digital presence via scientific networking platforms (e.g., ResearchGate, ORCID)

🎓 Education :

Dr. Al Haj earned his diploma and Master’s degrees in Biotechnology and Biochemistry from the University of Damascus, Syria. He later completed a Doctorate in Biology and Biotechnology with a dissertation on the modulation of cofilin/ADF and thymosin beta4 in cell migration. His academic pursuits also include studies in Educational Planning, Natural Sciences, and Microbiology at the Technical University of Applied Sciences Berlin and Ruhr University Bochum. Additionally, he undertook postgraduate training in Education and Psychology, Business English, and quality management under TÜV-certified programs. Dr. Al Haj further enriched his academic repertoire with continuous professional development courses in process management, norm standards (ISO 9001), and nutrition. His commitment to lifelong learning reflects a passion for combining theoretical science with applied clinical and educational practices.

🧪 Experience :

Dr. Al Haj has accumulated extensive research and teaching experience across several prestigious institutions. At the Ruhr University Bochum, he worked with Prof. Hans Georg Mannherz on actin-regulating proteins, contributing to innovative cardiology research. He held posts at Catholic and Central Clinics as a scientist, served as a paramedic at Herne Vaccination Center, and worked as a social worker and integration coach. His academic duties included teaching biology, chemistry, and physics, and serving as an Arabic language teacher in Berlin. Additionally, Dr. Al Haj took on project management and quality assurance roles at LVQ Further Education gGmbH and underwent TÜV training for process management. His unique blend of clinical, educational, and social service roles highlights his commitment to interdisciplinary collaboration and societal contribution.

🔬 Research Focus :

Dr. Al Haj’s research centers on molecular and experimental cardiology, cytoskeletal proteins (cofilin/ADF), and cell migration. His doctoral and postdoctoral work explored the effects of thymosin beta4 and actin-regulating proteins on cellular motility—essential for understanding cardiac development and cancer metastasis. His published work includes significant studies on the Arp2/3 complex, actin dynamics, and the influence of sGC activators on cardiac cells from hypertensive and heart failure patients. Beyond molecular cardiology, he has explored radioimmunoassay techniques, EBV-associated gastric carcinoma, and embryological development of cardiac muscle from branchial arch progenitors. His multidisciplinary approach blends biochemistry, histology, anatomy, and clinical diagnostics, bridging basic research with therapeutic applications. His ongoing interest in student assessment and e-learning underscores a commitment to scientific education and training.

📚 Publications Top Notes :

  1. 🧬 Inhibition of Arp2/3 Complex after ADP-Ribosylation of Arp2 by Binary Clostridioides Toxins – Cells, 2022

  2. ❤️ sGC Activator Causes Beneficial Remodeling in Cardiomyocytes from Hypertensive Rats and Heart Failure Patients – Front. Physiol.

  3. 🧠 Chicken Second Branchial Arch Progenitor Cells Contribute to Heart Musculature In Vitro and In Vivo – Developmental Dynamics, 2020

  4. 🧫 Characteristics of Gastric Carcinoma Associated with Epstein Barr Virus in Algeria – Der Pharmacia Lettre, 2017

  5. 🦴 Etiology and Pathogenesis of Arthrofibrosis at the Cellular Level – Arthroscopy, 2016

  6. 🧪 HeLa Cells and the Human Colon Carcinoma BE, 3LNLN and EB3 Cell Lines – Dissertation Work

  7. 🎓 Research on Assessing Students’ Academic Performance in Bloom’s Cognitive Level

🧾 Conclusion :

Dr. Abdulatif Al Haj is a strong candidate for the Innovative Research Award, distinguished by his relentless pursuit of molecular innovation, interdisciplinary approach, and commitment to public health and education. His work on actin-binding proteins and cardiac regeneration holds promising implications for heart disease treatment and personalized medicine. His track record demonstrates scientific creativity, rigor, and societal relevance.

Mrinal Saha | Cell Structure Analysis | Cell Biology Research Award

Published on by Cell Biologist

Dr. Mrinal Saha | Cell Structure Analysis | Cell Biology Research Award

Dr. Mrinal Saha , University of Oklahoma , United States

Dr. Mrinal C. Saha is a Professor at the School of Aerospace and Mechanical Engineering at the University of Oklahoma. He earned his PhD in Mechanical Engineering and Mechanics from Old Dominion University in 2001. With extensive experience in academia and research, Dr. Saha has made significant contributions to advanced materials and sensor technologies, including the development of self-powered sensors and environmental remediation technologies. His professional journey includes serving as Associate Professor and Assistant Professor at the University of Oklahoma. He is a seasoned researcher and innovator, holding patents and receiving various best paper awards. Throughout his career, he has been involved in interdisciplinary research, collaborating with experts across various fields to enhance engineering applications in structural health monitoring and nanocomposite technologies.

Publication Profile: 

Scopus

Strengths for the Award:

Mrinal C. Saha’s expertise in mechanical engineering, especially in material science and sensor technology, is highly relevant for interdisciplinary applications, including those in cell biology research. His research has focused on advanced materials such as composite structures, nanocomposites, and self-powered sensors, which could have implications for biosensors and medical devices used in cell biology. His work on embedding sensors in structures and developing multifunctional electrodes is particularly pertinent to cellular monitoring and bioengineering applications. Moreover, his collaborations with prominent researchers, as well as funding from various high-profile sources, demonstrate his ability to lead innovative projects with significant implications for multiple fields.

Areas for Improvement:

While Mrinal C. Saha’s work has an obvious focus on material science and mechanical engineering, his direct experience in cell biology research is less evident. Bridging the gap between his materials-focused research and cell biology could further enhance his suitability for the Cell Biology Research Award. Expanding his network to include collaborations with biologists and bioengineers could help integrate his expertise with biological research directly.

Education:

Dr. Mrinal C. Saha’s educational journey reflects his strong foundation in mechanical engineering. He obtained his PhD in Mechanical Engineering and Mechanics from Old Dominion University, Virginia, USA, in 2001. Before that, he earned an MS in Mechanical Engineering from Tuskegee University, Alabama, USA, in 1996. His academic journey began at the Bangladesh University of Engineering and Technology (BUET), Dhaka, where he completed both his MS and BS in Mechanical Engineering in 1992 and 1988, respectively. His education at BUET equipped him with a solid technical background that has supported his contributions to research in advanced composite materials, sensors, and nanotechnology. Dr. Saha’s academic credentials and his continuous pursuit of knowledge have played a crucial role in shaping his research career, allowing him to make significant strides in the field of mechanical engineering.

Experience:

Dr. Mrinal C. Saha brings a wealth of experience to his role as a Professor at the University of Oklahoma’s School of Aerospace and Mechanical Engineering. With a career spanning over two decades, Dr. Saha has held various academic positions, starting as an Assistant Professor in 2006, advancing to Associate Professor in 2012, and ultimately becoming a full Professor in 2018. Throughout his tenure at OU, he has been involved in cutting-edge research and educational development in the areas of structural health monitoring, additive manufacturing, and nanocomposites. Prior to his current role, Dr. Saha contributed to research initiatives at Tuskegee University, collaborating on high-profile projects with the National Science Foundation and the Federal Aviation Administration. His leadership and collaborative research efforts have resulted in numerous funded projects, publications, and significant technological advancements in aerospace and mechanical engineering.

Awards and Honors:

Dr. Mrinal C. Saha has earned multiple prestigious awards and recognitions for his research and academic contributions. He has been honored with best paper awards for his exceptional work in the areas of nanocomposite materials, sensors, and additive manufacturing. In addition to this, Dr. Saha holds a patent and has been involved in another patent disclosure, demonstrating his innovative contributions to the field. His research achievements have been recognized both nationally and internationally, underscoring his expertise and impact in mechanical and aerospace engineering. Dr. Saha’s work on embedded sensors, multifunctional electrodes, and self-powered technologies has led to significant advances in structural health monitoring and materials science. These accolades not only reflect his research capabilities but also his role as a leader in advancing engineering solutions for real-world applications. Dr. Saha’s continued success in securing research funding and publishing influential papers speaks to his academic excellence.

Research Focus:

Dr. Mrinal C. Saha’s research focuses on the development of advanced materials, self-powered sensors, and innovative manufacturing techniques. His work spans a wide range of areas, including nanocomposite materials, 3D printing, and multifunctional electrodes for environmental remediation and structural health monitoring. He specializes in the design and characterization of high-performance composite structures and sensors, emphasizing flexibility, sensitivity, and durability for various engineering applications. One of his primary research interests is the integration of embedded sensors into materials for real-time damage detection and monitoring. His work on electrospun nanofibers, piezoelectric nanogenerators, and flexoelectric sensors has led to groundbreaking advancements in self-powered systems for aerospace, automotive, and biomedical industries. Dr. Saha’s research is multidisciplinary, blending mechanical engineering, materials science, and sensor technologies to address challenges in the design and performance of smart structures and sustainable engineering solutions.

Publications Top Notes:

  1. Mondal, A., Saha, M.C., Rhule, D. (2025). Experimental Investigation of In-Plane Compressive Characteristics of 3D-Printed Carbon Fiber-Reinforced Epoxy Composite Honeycomb Cores 🏗️📑
  2. Mondal, A., Saha, M.C. (2025). Characterization of In-plane Compressive Response of Triangular Honeycomb Carbon Fiber Epoxy Composites 🧱📚
  3. Maity, K., Saha, M.C. (2025). Design of Flexible and Ultrasensitive 3D Printed Flexoelectric Sensors for Self-Powered Damage Detection ⚡🔧
  4. Mondal, A., Saha, M.C., Maity, K., Altan, M.C., Liu, Y. (2023). Analysis of Fiber Flow, Fiber Orientation, and Void Formation in Material Extrusion of Short Carbon Fiber Epoxy Composites 🧵📊
  5. Rhule, D., Mondal, A., Saha, M.C., Cummings, L., Robison, T. (2023). Effect of Silica and Mixing Time on Microstructures and Properties of Porous Polymer Composite 🧪🧬
  6. Mondal, A., Saha, M.C. (2023). 3D Printing and Characterization of Carbon Fiber Epoxy Composites 🖨️🔬

Conclusion:

Mrinal C. Saha’s background in materials science, sensor technology, and advanced manufacturing methods makes him a strong candidate for the Cell Biology Research Award, provided there is a greater focus on integrating his research with biological applications. His innovative work in sensors and nanocomposites could significantly contribute to advancing biosensors, tissue engineering, and other cell biology-related fields.

Erdal Dinç | Cell Biology Research Award | Best Researcher Award

Published on by Cell Biologist

prof. Dr. Erdal Dinç | Cell Biology Research Award | Best Researcher Award

Prof. Dr. Erdal Dinç , Ankara University, Faculty of Pharmacy, Department of Analytical Chemistry , Turkey

Erdal Dinç is a distinguished professor of Analytical Chemistry at the Faculty of Pharmacy, Ankara University, Turkey. With a prolific academic career, he has authored 195 research papers in SCI-indexed journals and 133 in Scopus-indexed journals. His work has received approximately 3013 citations, and he has an H-index of 29. His research interests focus on developing novel analytical methods for drug-DNA interactions, drug analysis, and the characterization of nano-films on modified electrode systems. Prof. Dinç has also contributed to books and conference proceedings in the field of analytical chemistry. Known for his significant contributions to chemometrics, chromatography, and spectroscopy, he has shaped the field with his innovative approaches in analytical methodologies, paving the way for advancements in pharmaceutical, food, and biological sciences.

Publication Profile:

Scopus

Strengths for the Award:

Professor Erdal Dinç is a distinguished academic with substantial contributions to analytical chemistry, particularly in the areas of drug analysis, drug-DNA interaction studies, and the development of new analytical methods. His impressive publication record includes 195 research papers in SCI-indexed journals and 133 in Scopus-indexed journals. His work has been cited over 3000 times, demonstrating a significant impact on the field. Additionally, his work on chemometrics, spectroscopy, and chromatography, along with his involvement in multiple ongoing research projects, showcases his innovative approach to solving complex analytical problems.

Areas for Improvement:

While Professor Dinç has an outstanding record in publishing and advancing analytical chemistry, expanding his collaborations internationally could further enhance the global reach and influence of his research. Additionally, translating some of his advanced techniques into more practical, industry-applicable tools could widen the real-world impact of his work.

Education:

Prof. Erdal Dinç completed his undergraduate education in Chemistry at the University of Ankara, followed by a master’s and Ph.D. in Analytical Chemistry. His doctoral research focused on chemometric approaches in chromatographic and spectroscopic analyses, which laid the foundation for his extensive career in the field. Over the years, he has been involved in numerous international collaborations and research programs. He continues to mentor graduate and post-graduate students in his field, guiding them through advanced research techniques and methodologies. His academic journey reflects a commitment to knowledge advancement, and his continuous work in both theoretical and applied chemistry makes him a leading figure in analytical sciences.

Experience:

Prof. Erdal Dinç has over 20 years of academic experience at Ankara University, where he has taught various analytical chemistry courses and supervised numerous research projects. His extensive research expertise spans across multiple areas, including spectrophotometry, chromatography, chemometrics, and drug analysis. Throughout his career, Prof. Dinç has led several significant research projects, many of which have been funded by organizations like TÜBİTAK and Ankara University. His work involves pioneering new methods for analyzing drug-DNA interactions, bioanalysis, and plant analysis. His academic contributions are reflected in his published articles and books, making him a globally recognized expert in the field of analytical chemistry. Prof. Dinç has been a key player in advancing chemical analysis in pharmaceutical, biological, and food sciences, and his work continues to inspire new generations of researchers.

Awards and Honors:

Prof. Erdal Dinç has received numerous accolades in recognition of his significant contributions to analytical chemistry. His research, spanning over two decades, has earned him national and international recognition in the field. Notably, he has been a recipient of several prestigious research grants from TÜBİTAK (The Scientific and Technological Research Council of Turkey) and Ankara University, facilitating cutting-edge work in drug analysis and chemical methodologies. His scientific achievements are further acknowledged by his high citation index and H-index of 29, which reflect his influence and reputation in the global scientific community. Prof. Dinç’s expertise in spectroscopic analysis and chemometric techniques has made him a sought-after researcher and speaker at conferences, where he shares his innovative methodologies with professionals worldwide. His work continues to impact the development of analytical tools and techniques in various sectors of science and industry.

Research Focus:

Prof. Erdal Dinç’s research focuses on the development of innovative analytical techniques for drug analysis, particularly in the areas of drug-DNA interaction studies, drug quantification, and the characterization of complex mixtures. His work explores advanced methods in chromatography (HPLC, UPLC), voltammetry, and spectrophotometry (UV-VIS, spectrofluorimetry, IR). He is particularly interested in applying chemometrics to resolve complex analytical problems, such as multi-component pharmaceutical formulations and kinetic reaction monitoring in biological and food samples. Prof. Dinç has developed novel models for analyzing interactions at the molecular level, such as those between pharmaceuticals and DNA, which can help in understanding drug efficacy and safety. Additionally, his research extends to the analysis of food products, biological fluids, and plant compounds, where he applies multidimensional spectral techniques to improve analytical accuracy and precision.

Publications Top Notes:

  1. Dinç, E., & Üçer, A. (2025). A new three-dimensional modeling of fluorescence excitation-emission measurements to explore the interaction of hydroxychloroquine and DNA, and to quantify their binding constant. Colloids and Surfaces B: Biointerfaces 💊🧬
  2. Üçer A., Ertekіn Z.C., Dіnç E (2024). A comparative application of spectrophotometric and spectrofluorimetric methods to estimate levofloxacin-DNA and ofloxacin-DNA interactions. Journal of Fluorescence 🔬🧫
  3. Üstündağ, Ö., & Dinç, E. (2024). A Rapid DMeyer-CWT Method Application to the Spectrophotometric Data for the Quantification of Losartan Potassium and Hydrochlorothiazide in a Binary Mixture. Sakarya University Journal of Science 💊⚙️
  4. Ertekin, Z. C., Büker, E., Oral, E. V., & Dinç, E. (2024). Application of continuous wavelet transforms for simultaneous estimation of domperidone and lansoprazole in capsule formulations. Measurement 💊📊
  5. Üçer, A., Üstündağ, Ö., & Dinç, E. (2023). Monitoring ascorbic acid oxidation with H2O2 and analyzing food supplements using parallel factor analysis model. Journal of Food Composition and Analysis 🍊🔬
  6. Di̇Nç, E., Üçer, A., Ünal, N. (2023). A multiway spectral analysis model to monitor the kinetic chlorination reaction of caffeine in commercial drinks. Food Chemistry 🥤☕

Conclusion:

Professor Erdal Dinç’s expertise, prolific publication record, and innovative research make him a strong candidate for the Best Researcher Award. His contributions to analytical chemistry are commendable, and with continued focus on global collaborations and practical applications, his future work could have even broader implications for the field.

 

 

Hatice Yesim Karasulu | Cell Differentiation Processes | Best Innovation Award

Published on by Cell Biologist

Prof. Dr. Hatice Yesim Karasulu | Cell Differentiation Processes | Best Innovation Award

Prof. Dr. Hatice Yesim Karasulu , Ege University, Faculty of Pharmacy, Pharmaceutical Technology , Turkey

Prof. Dr. H. Yeşim Karasulu is a distinguished academic and researcher in pharmaceutical technology, based at Ege University in Turkey. With a career spanning decades, she earned her Ph.D. in Pharmaceutical Technology from Ege University, where she became an Associate Professor in 2006 and a full Professor in 2011. Prof. Karasulu has held numerous positions, including consultant for the Ege University Center for Drug Research & Development (ARGEFAR) and member of the pharmaceutical technology commission at Turkey’s Ministry of Health from 2006 to 2024. She has contributed extensively to drug delivery systems and pharmaceutical formulations, especially focusing on colloidal drug delivery. Over the years, she has published over 50 research papers, authored five book chapters, and is the holder of two patents related to nano-drug delivery systems. Her work has advanced both academic knowledge and pharmaceutical industry practices.

Publication Profile:

Google Scholar

Strengths for the Award:

  1. Extensive Research Experience: Prof. Dr. H. Yeşim Karasulu has an exceptional track record with more than 50 publications, multiple patents, and ongoing research projects. Her innovative work in colloidal drug delivery systems, including liposomes, nano/microparticles, nano/microemulsions, and self-emulsifying drug delivery systems (SEDDS), positions her as a leading researcher in the pharmaceutical field.
  2. High Impact and Collaboration: Her research is widely cited with an H-index of 16 (WoS) and 18 (Scopus). She has collaborated with prestigious institutions such as the University of Vienna and the Aristotle University of Thessaloniki, further enhancing the global impact of her work.
  3. Patent and Industry Collaboration: Prof. Karasulu’s research has led to two patents and several patent applications, showcasing the practical and commercial value of her innovations. Additionally, her collaborative efforts with the pharmaceutical industry in developing drug delivery systems highlight her ability to bridge academia and industry, enhancing the potential for real-world applications.
  4. Ongoing Research Projects: Prof. Karasulu is involved in multiple research projects, both academic and industry-sponsored, demonstrating her continuous commitment to advancing pharmaceutical sciences. Her ongoing projects include drug delivery systems targeting specific organs and improving drug bioavailability and stability.
  5. Awards and Recognition: Prof. Karasulu’s achievements are recognized through awards such as the Ege ArGe First Prize and the Ege ArGe Innovation Award, confirming the innovative nature of her research.

Areas for Improvement:

  1. Broader International Visibility: While Prof. Karasulu has a strong track record within her field, expanding her international visibility by increasing collaborations with leading global pharmaceutical companies could further enhance the global reach and impact of her innovations.
  2. Diversity of Published Works: Though Prof. Karasulu has an impressive number of publications, exploring opportunities for publication in high-impact journals outside her primary research focus could enhance her visibility in other areas of pharmaceutical sciences.
  3. Focus on Translational Research: While there is a strong emphasis on preclinical studies and formulation development, further focus on clinical trials and commercialization of her innovations could enhance the practical application of her work, especially with regard to regulatory approval processes for new drug delivery systems.

Education:

Prof. Dr. H. Yeşim Karasulu pursued her academic studies at Ege University in Izmir, Turkey. She completed her Bachelor’s degree in Pharmacy at the Faculty of Pharmacy before obtaining a Ph.D. in Pharmaceutical Technology from the same institution. Her education continued with postdoctoral research at the University of Vienna, focusing on Pharmaceutical Technology and Biopharmaceutics under the guidance of Prof. Dr. Franz Gabor. This international research experience allowed her to expand her expertise in colloidal drug delivery systems, setting the foundation for her career as a researcher. Throughout her education, Prof. Karasulu’s work has concentrated on the development of drug delivery systems, with an emphasis on enhancing the bioavailability and targeting of drugs using innovative methods like liposomes, nano/microparticles, and microemulsions. Her academic background has enabled her to contribute significantly to both research and industry practices in pharmaceutical sciences.

Experience:

Prof. Dr. H. Yeşim Karasulu has a distinguished career in both academia and the pharmaceutical industry. She began her academic career as a faculty member at Ege University, where she progressed from an Assistant Professor to a full Professor in the Department of Pharmaceutical Technology. Additionally, she has been an active consultant at the Ege University Center for Drug Research & Development (ARGEFAR) since 2011. Prof. Karasulu also served as a member of the Pharmaceutical Technology Commission at the Turkish Ministry of Health’s Pharmaceuticals and Medical Devices Agency between 2006 and 2024, helping shape national pharmaceutical policies. Her extensive research has led to breakthroughs in nano-drug delivery systems, contributing to the development of two patents and several industry projects. She has worked on numerous national and international projects focusing on drug formulation, bioavailability enhancement, and targeting systems, particularly for cancer therapy and chronic diseases.

Research Focus:

Prof. Dr. H. Yeşim Karasulu’s research primarily focuses on the development and evaluation of advanced colloidal drug delivery systems. Her work spans liposomes, nano/microparticles, nano/microemulsions, and self-emulsifying drug delivery systems (SEDDS). These innovative systems aim to enhance the bioavailability, stability, and targeted delivery of pharmaceutical compounds. Prof. Karasulu has led several high-impact research projects funded by both national (TUBİTAK) and international bodies, such as the European Union. Her research is dedicated to improving the therapeutic efficacy of drugs, particularly in challenging areas like cancer treatment and chronic diseases. Prof. Karasulu’s work is closely aligned with real-world applications, as evidenced by her ongoing collaboration with the pharmaceutical industry to bring new drug delivery systems to market. Her goal is to create formulations that not only improve patient outcomes but also contribute to the overall advancement of pharmaceutical technology.

Publications Top Notes:

  1. “Degradation and gastrointestinal stability of nitrofurantoin in acidic and alkaline media” 📉💊
  2. “Sustained-release dosage form of nitrofurantoin: Part 1. Preparation of microcapsules and in vitro release kinetics” 💊🔬
  3. “33 factorial design-based optimization of the formulation of nitrofurantoin microcapsules” 🔬📊
  4. “In vitro-in vivo correlations of nitrofurantoin matrix tablet formulation” 💊⚖️
  5. “A New In Vitro/In Vivo Kinetic Correlation Method for Nitrofurantoin Matrix Tablet Formulations” 🧪💡
  6. “Sustained release bioadhesive effervescent ketoconazole microcapsules tabletted for vaginal delivery” 💊💥
  7. “Different geometric shaped hydrogel theophylline tablets: Statistical approach for estimating drug release” 💊📐
  8. “Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates” 💊🔢
  9. “Improving of the accuracy of in vitro-in vivo linear correlation using kinetic models for ultra sustained release theophylline tablets” 🧪📊
  10. “Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida Albicans” 💊🦠
  11. “Preparation of arsenic trioxide-loaded microemulsion and its enhanced cytotoxicity on MCF-7 breast carcinoma cell line” 🔬🧪
  12. “In vitro permeation of diclofenac sodium from novel microemulsion formulations through rabbit skin” 💊🐇
  13. “Arsenic trioxide-loaded, microemulsion-enhanced cytotoxicity on MDAH 2774 ovarian carcinoma cell line” 🔬💉
  14. “Transdermal delivery of diclofenac sodium through rat skin from various formulations” 💊🦷
  15. “Controlled release of methotrexate from W/O microemulsion and its in vitro anti-tumor activity” 🧪💥

Conclusion:

Prof. Dr. H. Yeşim Karasulu is a highly deserving candidate for the Best Innovation Award. Her groundbreaking research in colloidal drug delivery systems has significantly contributed to advancements in pharmaceutical sciences. With numerous publications, patents, and collaborations, her work not only pushes the boundaries of scientific research but also has a profound impact on drug development. By focusing on broader international collaborations and further developing translational research strategies, Prof. Karasulu’s contributions to the pharmaceutical industry and academic community will continue to grow, solidifying her place as a leader in innovation.